Previously infected vaccinees broadly neutralize SARS-CoV-2 variants

We compared the serum neutralizing antibody titers before and after two doses of the BNT162b2 COVID-19 vaccine in ten individuals who recovered from SARS-CoV-2 infection prior to vaccination to 20 individuals with no history of infection, against clinical isolates of B.1.1.7, B.1.351, P.1, and the o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:medRxiv
Asıl Yazarlar: Leier, Hans C., Bates, Timothy A., Lyski, Zoe L., McBride, Savannah K., Lee, David X., Coulter, Felicity J., Goodman, James R., Lu, Zhengchun, Curlin, Marcel E., Messer, William B., Tafesse, Fikadu G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cold Spring Harbor Laboratory 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8095208/
https://ncbi.nlm.nih.gov/pubmed/33948601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.25.21256049
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller